Dragan Isailovic

Dr. Dragan Isailovic

Department of Chemistry and Biochemistry, University of Toledo, Toledo, OH 43606, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in Environmental Science & Technology
Verified
Journal Article
Closed access
DBDavid Baliu-Rodriguez
David Baliu-Rodriguez
NPNicholas J. Peraino
Nicholas J. Peraino
SPSanduni H. Premathilaka
Sanduni H. Premathilaka
JBJohnna A. Birbeck
Johnna A. Birbeck
TBTomás Baliu-Rodriguez
Tomás Baliu-Rodriguez
Dragan IsailovicDragan Isailovic
Dragan Isailovic

19 March 2022 in Antioxidants
Verified
Journal Article
Open access
PDF file
CMChrysan J. Mohammed
Chrysan J. Mohammed
SLSabitri Lamichhane
Sabitri Lamichhane
JCJacob Connolly
Jacob Connolly
SSSophia M. Soehnlen
Sophia M. Soehnlen
FKFatimah Khalaf
Fatimah Khalaf
DKDavid J. Kennedy
David J. Kennedy
Paraoxonases (PONs) are a family of hydrolytic enzymes consisting of three members, PON1, PON2, and PON3, located on human chromosome 7. Identifying the physiological substrates of these enzymes is necessary for the elucidation of their biological roles and to establish their applications in the biomedical field. PON substrates are classified as organophosphates, aryl esters, and lactones based on their structure. While the established native physiological activity of PONs is its lactonase activity, the enzymes’ exact physiological substrates continue to be elucidated. All three PONs have antioxidant potential and play an important anti-atherosclerotic role in several diseases including cardiovascular diseases. PON3 is the last member of the family to be discovered and is also the least studied of the three genes. Unlike the other isoforms that have been reviewed extensively, there is a paucity of knowledge regarding PON3. Thus, the current review focuses on PON3 and summarizes the PON substrates, specific activities, kinetic parameters, and their association with cardiovascular as well as other diseases such as HIV and cancer.

23 August 2019 in Toxins
Verified
Journal Article
Open access
PDF file
Apurva LadApurva Lad
Apurva Lad
RSRobin Su
Robin Su
JBJoshua Breidenbach
Joshua Breidenbach
PSPaul Stemmer
Paul Stemmer
NCNicholas J. Carruthers
Nicholas J. Carruthers
DKDavid J. Kennedy
David J. Kennedy
Microcystins are potent hepatotoxins that have become a global health concern in recent years. Their actions in at-risk populations with pre-existing liver disease is unknown. We tested the hypothesis that the No Observed Adverse Effect Level (NOAEL) of Microcystin-LR (MC-LR) established in healthy mice would cause exacerbation of hepatic injury in a murine model (Leprdb/J) of Non-alcoholic Fatty Liver Disease (NAFLD). Ten-week-old male Leprdb/J mice were gavaged with 50 μg/kg, 100 μg/kg MC-LR or vehicle every 48 h for 4 weeks (n = 15–17 mice/group). Early mortality was observed in both the 50 μg/kg (1/17, 6%), and 100 μg/kg (3/17, 18%) MC-LR exposed mice. MC-LR exposure resulted in significant increases in circulating alkaline phosphatase levels, and histopathological markers of hepatic injury as well as significant upregulation of genes associated with hepatotoxicity, necrosis, nongenotoxic hepatocarcinogenicity and oxidative stress response. In addition, we observed exposure dependent changes in protein phosphorylation sites in pathways involved in inflammation, immune function, and response to oxidative stress. These results demonstrate that exposure to MC-LR at levels that are below the NOAEL established in healthy animals results in significant exacerbation of hepatic injury that is accompanied by genetic and phosphoproteomic dysregulation in key signaling pathways in the livers of NAFLD mice.

1 July 2018 in Journal of Chromatography A
Verified
Journal Article
Closed access
ADAmila M. Devasurendra
Amila M. Devasurendra
DPDilrukshika S.W. Palagama
Dilrukshika S.W. Palagama
Ahmad RohanifarAhmad Rohanifar
Ahmad Rohanifar
Dragan IsailovicDragan Isailovic
Dragan Isailovic
JKJon Kirchhoff
Jon Kirchhoff
JAJared L. Anderson
Jared L. Anderson

17 August 2018 in Journal of Chromatography A
Verified
Journal Article
Closed access
DPDilrukshika S.W. Palagama
Dilrukshika S.W. Palagama
DBDavid Baliu-Rodriguez
David Baliu-Rodriguez
ALApurva Lad
Apurva Lad
BLBruce S. Levison
Bruce S. Levison
DKDavid J. Kennedy
David J. Kennedy
Dragan IsailovicDragan Isailovic
Dragan Isailovic

1 April 2020 in Journal of Great Lakes Research
Verified
Journal Article
Closed access
DPDilrukshika S.W. Palagama
Dilrukshika S.W. Palagama
DBDavid Baliu-Rodriguez
David Baliu-Rodriguez
BSBrenda K. Snyder
Brenda K. Snyder
JTJennifer A. Thornburg
Jennifer A. Thornburg
TBThomas B. Bridgeman
Thomas B. Bridgeman
Dragan IsailovicDragan Isailovic
Dragan Isailovic